-
All Resources
(choose a category)
-
All Resources
-
Evidence
Evidence, advice, guidance and standards
-
Improvement
Improvement and implementation support
-
Scrutiny
Assurance, scrutiny, measurement and reporting
-
-
Healthcare Area
- Dermatology
- Musculoskeletal system
- Resource Type
- Programme
- Year
- Page 1 of 1
8 results found filtered by Dermatology Remove Dermatology Filter Clear Search
-
Skincare of patients receiving radiotherapy
- Published
- 19 April 2010
- Cycle of Improvement
- Evidence
-
Appraisal Guidance No 180 – Ustekinumab for the treatment of adults withmoderate to severe psoriasis
- Published
- 24 February 2010
- Cycle of Improvement
- Evidence
-
Appraisal Guidance No 177 – Alitretinoin for the treatment of severe chronic hand eczema
- Published
- 26 August 2009
- Cycle of Improvement
- Evidence
-
NICE Single Technology Apprasial Guidance 140 and 141
- Published
- 23 April 2008
- Cycle of Improvement
- Evidence
-
Appraisal Guidance No 134 Infliximab for the treatment of adults with psoriasis
- Published
- 23 January 2008
- Cycle of Improvement
- Evidence
-
Appraisal Guidance No 133 – Omalizumab for severe persistent allergic asthma
- Published
- 28 November 2007
- Cycle of Improvement
- Evidence
-
Appraisal Guidance 125: Adalimumab for the treatment of psoriatic arthritis
- Published
- 22 August 2007
- Cycle of Improvement
- Evidence
-
Appraisal Guidance No 103 Etanercept and efalizumab for adults with psoriasis
- Published
- 26 July 2006
- Cycle of Improvement
- Evidence